BRIEF-Alnylam Pharmaceuticals Q2 Adjusted EPS USD 1.84 Vs. IBES Estimate USD 1.55
Reuters2026/07/30 12:01Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Jul 30 (Reuters) - Alnylam Pharmaceuticals Q2 revenue USD 1,290.948 million vs. IBES estimate USD 1,323 million.
- Q2 adjusted net income USD 251.801 million
- Q2 adjusted operating income USD 318.066 million
- Q2 operating income USD 231.441 million
- Q2 net income USD 164.494 million
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
ICP Price Falls Over 99% From ATH as Bearish Pressure Builds Near $2.17
CoinCryptoNewz•2026/08/16 09:12
Tether to launch its USDT stablecoin on the Kava blockchain
The Block•2026/08/16 08:21
MakerDAO purchases $700 million in Treasury bonds, grows holdings to $1.2 billion
The Block•2026/08/16 08:21
Crypto prices
More
Bitcoin
BTC
$63,000.8
+0.18%
Ethereum
ETH
$1,879.64
+0.21%
Tether USDt
USDT
$0.9988
-0.01%
USDC
USDC
$0.9998
-0.01%
XRP
XRP
$1
+0.02%
Solana
SOL
$75.36
+0.43%
TRON
TRX
$0.3308
-0.36%
Hyperliquid
HYPE
$57.44
+2.52%
Dogecoin
DOGE
$0.06980
-0.15%
Zcash
ZEC
$487.37
-0.18%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now